Optimisation of ASthma In Those With Uncontrolled Symptoms (OASIS)

Guy's and St Thomas' NHS Foundation Trust

Status: Completed

Conditions: Asthma Attack; Asthma Persistent; Asthma; Covid19

Treatments: Device: ReferID

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT04941001

274450

Details and patient eligibility

About

A digital tool, called ReferID has been developed to facilitate the review of asthma patients. It aims to assist in the identification of patients with uncontrolled and/or severe asthma and to ensure a timely referral to secondary care where appropriate. To validate the tool, patients will be randomised to have a review with a healthcare professional using tool to facilitate the review or to continue receiving usual care. Outcome measures including exacerbation frequency and level of asthma control will be assessed at 12 months.

Enrollment: 202 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• All asthma patients with 1 of more exacerbations in the last 12 months or receiving high dose inhaled corticosteroids.
• Patients able and willing to provide informed consent.
• Patients aged 18 and over.

Exclusion criteria

• Patients who lack capacity.
• Patients who do not have a diagnosis of asthma
• Patients who are unable to provide informed consent
• Patients under the age of 18
• Patients already under a severe asthma centre

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

202 participants in 2 patient groups

Healthcare professional using ReferID Tool in primary care

Active Comparator group

Description:

The asthma review will be undertaken by a healthcare professional with the use of the ReferID tool in primary care

Treatment:

Device: ReferID

Usual care in primary care

No Intervention group

Description:

A cohort of patients will be recruited who continue to receive usual care in primary care